Sol-Gel Technologies (SLGL) Property, Plant & Equipment (Net) Growth (5y) (2021 - 2026)

Sol-Gel Technologies (SLGL) Property, Plant & Equipment (Net) Growth (5y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Sol-Gel Technologies 226.64 Mn 216.50 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -39.00%
Dec 31, 2025 -40.11%
Sep 30, 2025 -41.11%
Jun 30, 2025 -40.66%
Mar 31, 2025 -40.05%
Dec 31, 2024 -38.60%
Sep 30, 2024 -36.44%
Jun 30, 2024 -34.10%
Mar 31, 2024 -31.94%
Dec 31, 2023 -30.12%
Sep 30, 2023 -27.67%
Jun 30, 2023 -25.49%
Mar 31, 2023 -23.40%
Dec 31, 2022 -22.19%
Dec 31, 2021 5.66%